As of September 2024, Lavipharm has a market cap of $153.03M. This makes Lavipharm the world's 18947th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $163.60M | 10.80% |
2023 | $147.65M | 107.29% |
2022 | $71.23M | -33.79% |
2021 | $107.58M | 247.31% |
2018 | $30.98M | 1.83% |
2017 | $30.42M | 90.70% |
2016 | $15.95M | -38.57% |
2015 | $25.97M | 2.19% |
2014 | $25.41M | 5.38% |
2013 | $24.11M | -18.75% |
2012 | $29.68M | - |